What is the BMI indication for Plenity?

Plenity is indicated for individuals with a body mass index (BMI) in the range of 25 to 40, which classifies them as overweight to moderately obese. This medication is designed to assist in weight management by mimicking the feeling of fullness, thereby helping patients reduce their caloric intake.

The rationale behind the specified BMI range is that individuals within this classification often face increased health risks associated with excess weight, such as cardiovascular disease, type 2 diabetes, and other obesity-related health conditions. By targeting this demographic, Plenity can provide a supportive measure in conjunction with diet and exercise, aiming to facilitate weight loss and improve overall health.

Other BMI categories either fall below or above the specified therapeutic range for Plenity. Individuals with a BMI under 25 are generally considered at a healthy weight and would not typically need pharmacological support for weight loss. Conversely, those with a BMI above 40 fall into the category of severe obesity, where different types of intervention, often more intensive, may be required. Thus, the chosen range of 25 to 40 aligns well with the intended use and indication for Plenity.